Want to cut red tape: ICMR on Covid-19 vaccine deadline

July 04, 2020 20:01

As experts cautioned against rushing the process for developing a COVID-19 vaccine after the Indian Council of Medical Research stated it plans to launch one by August 15, the apex health research body on Saturday stressed that it is acting in accordance with the globally accepted norms to fast-track vaccine development for diseases of pandemic potential.

The ICMR said that the letter by Director General of ICMR Dr Balram Bhargava to principal investigators of the clinical trial sites was meant to cut unnecessary red tape, without bypassing any necessary process, and speed up recruitment of participants.

Bhargava had on July 2 written to principal investigators of select medical institutions and hospitals to fast-track human clinical trial approvals for the vaccine candidate 'Covaxin' being developed in collaboration with Bharat Biotech.

All other vaccine candidates across the globe have been similarly fast-tracked, it said, adding that the Drugs Controller General of India has accorded permission to conduct phase 1 and 2 (human) clinical trial of 'Covaxin' based on in-depth scrutiny of the available data from pre-clinical studies.

Just as red tape was not allowed to become a hindrance in the fast track approval of new indigenous testing kits or for introducing in the Indian market potential COVID-19 related drugs, the indigenous vaccine development process has also been sought to be insulated from slow file movement, it said.

"The aim is to complete these phases at the earliest, so that population-based trials for efficacy could be initiated without delay," ICMR said in a statement.

After intense characterisation and review of all data from BBIL, the ICMR said it is supporting the clinical development as the vaccine candidate appears to be promising.

In the larger public health interest, it is important for ICMR to expedite the clinical trials with a promising indigenous vaccine, the statement stated.

Faced with the unprecedented nature of the COVID-19 pandemic, and the consequent dislocation of the normal life, all other vaccine candidates across the globe have been similarly fast-tracked, it said.

"ICMR's process is exactly in accordance with the globally accepted norms to fast-track the vaccine development for diseases of pandemic potential wherein human and animal trials can continue in parallel," it said.

Underlining ICMR was among the world's most reputed organisations in the field of medical research and its track record of facilitating India's globally respected and acknowledged vaccine and drug industry speaks for itself, the research body said trials will be done following the best practices and rigour. -- PTI

« Back to LIVE

TOP STORIES

SC may consider Kejriwal's bail plea on Tuesday over LS polls

A bench of justices Sanjiv Khanna and Dipankar Datta told Additional Solicitor General SV Raju, appearing for the Enforcement Directorate, that the hearing on Kejriwal's plea against arrest is likely to take time and therefore, the court...

IPL: 'Batting outside the Powerplay is the hardest thing'

England all-rounder Will Jacks has slammed hundreds in SA20, BPL and IPL within the first five months of 2024.

It's just the beginning for Rinku: Ganguly

Rinku Singh shouldn't be disheartened by his exclusion from India's World T20 squad as it was pure tactical decision, said former captain Sourav Ganguly.

JD-S worker steps up, accuses Prajwal of rape, filming it

The crime investigation department booked Prajwal, grandson of former prime minister HD Deve Gowda, after a JD-S worker from Hassan lodged a complaint against him.

Prajwal Revanna booked for rape, says CM Siddaramaiah

He said he has directed police to identify, trace and secure the victims in view of the alleged kidnapping of a victim at Krishnaraja Nagar town in Mysuru district.